Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    weill AND mri of liver | Open Studies
Show Display Options
Rank Status Study
1 Unknown  Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Condition: Hepatic Fibrosis
Intervention: Procedure: MRI of liver
2 Unknown  MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
Condition: Myelodysplastic Syndrome (MDS)
Intervention: Other: T2* Cardiac and Liver MRI
3 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
4 Recruiting An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
Conditions: Erythrocyte Transfusion;   Beta-Thalassemia
Interventions: Drug: Luspatercept;   Other: Placebo

Indicates status has not been verified in more than two years